Mytelase
Mytelase
Mytelase (pronounced: my-tel-ase), also known as Ambenoium Chloride, is a medication used in the treatment of myasthenia gravis, a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness.
Etymology
The term "Mytelase" is derived from the words "my" (referring to muscle), "tel" (from the Greek word 'telos' meaning end or purpose), and "ase" (a common suffix for enzymes). The name suggests the drug's purpose in targeting muscle enzymes.
Usage
Mytelase is a cholinesterase inhibitor, which means it works by improving nerve impulses in muscles so that the muscles are better able to work. It is used to manage the symptoms of myasthenia gravis such as weakness in the arm and leg muscles, double vision, drooping eyelids, and difficulties with speech, chewing, swallowing, and breathing.
Side Effects
Common side effects of Mytelase include nausea, vomiting, diarrhea, stomach cramps, increased saliva/mucus, decreased pupil size, and increased urination. Serious side effects may include new or increased muscle weakness, slow/irregular heartbeat, or seizures.
Related Terms
See Also
External links
- Medical encyclopedia article on Mytelase
- Wikipedia's article - Mytelase
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski